Catalyst Wire Dossier Catalyst Wire Dossier

Darolutamide

darolutamide · Bayer
Drug timelines are a Plus or Pro feature.

41 regulatory and trial events tracked for Darolutamide, covering 2019-10-29 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment

See pricing